Clomipramine treatment in neonatal rats alters the brain acetylcholinesterase activity in adulthood

Neuroscience Letters

Volumn 330, Issue 1, 2002, Pages 119-121

  Mavanji, Vijayakumar ^a,b   Datta, Subimal ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Acetylcholinesterase; Animal model; Clomipramine; Endogenous depression

Indexed keywords

CHOLINESTERASE; CLOMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTUM PELLUCIDUM;

ACETYLCHOLINESTERASE; AGING; ANIMALS; ANIMALS, NEWBORN; BRAIN; CLOMIPRAMINE; DEPRESSION; ENZYME ACTIVATION; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR;

EID: 0037072536     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00725-5     Document Type: Article

References (22)

1. Allegri R.F., Harris P. Prefrontal cortex in memory and attention process. Rev. Neurol. 32:(5):2001;449-453.
2. Atack J.R., Perry E.K., Bonham J.R., Candy J.M., Perry R.H. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J. Neurochem. 47:1986;263-277.
3. Das A., Dikshit M., Nath C. Profile of acetylcholinesterase in brain areas of male and female rats of adult and old age. Life Sci. 68:2001;1545-1555.
4. Datta S. Neuronal activity in the peribrachial area: relationship to behavioral state control. Neurosci. Biobehav. Rev. 19:1995;67-84.
5. Ellman G.L., Courtney K.D., Andres V., Feaherstone R.M. A new colorimetric determination of acetylcholinestrase activity. Biochem. Pharmacol. 7:1961;88-95.
6. Flicker C., Dean R.L., Fisher S.K., Bartus R.T. Behavioral and neurochemical effects following neurotoxic lesioning of a major cholinergic input to the cerebral cortex in the rats. Pharmacol. Biochem. Behav. 18:1983;973-981.
7. Hobson J.A., Pace-Schott E.F., Stickgold R. Dreaming and the brain: toward a cognitive neuroscience of conscious states. Behav. Brain Sci. 23:2000;793-1121.
8. Janowsky D.S., El-Yosef M.K., Davis J.M., Sekerke H.J. A cholinergic and adrenergic hypothesis of mania and depression. Lancet. 2:1972;632-635.
9. Janowsky D.S., Overstreet D.S. The role of acetylcholine mechanisms in mood disorders. Bloom F.E., Kupfer D.J., Psychopharmacology: The 4th Generation of Progress. 1995;945-956 Raven Press, New York.
10. Kopf S.R., Buchholzer M.L., Hilgert M., Loffelholz K., Klein J. Glucose plus choline improve passive avoidance behavior and increase hippocampal acetylcholine release in mice. Neuroscience. 103:2001;365-371.
11. Mavanji V.K., Meti B.L. Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression. Neurochem. Res. 24:(3):1999;345-349.
12. Mirmiran M., Van De Poll N.E., Corner M.A., Van Oyen H.G., Bour H.L. Suppression of active sleep by chronic treatment with clomipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res. 204:1981;129-146.
13. Mortensen S.R., Hooper M.J., Padilla S. Rat brain acetylcholinesterase activity: developmental profile and maturational sensitivity to carbamate and organophosphorous inhibitors. Toxicology. 125:1998;13-19.
14. Muller F., Dumez Y., Massoulie J. Molecular forms and solubility of acetylcholinesterase during the embryonic development of rat and human brain. Brain Res. 331:1985;295-302.
15. Prathiba J., Kumar K.B., Karanth K.S. Effect of REM sleep deprivation on cholinergic receptor sensitivity and passive avoidance behavior in clomipramine model of depression. Brain Res. 867:2000;243-245.
16. Ridley R.M., Murray T.K., Johnson J.A., Baker H.F. Learning impairments following lesions of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs. Brain Res. 376:1986;108-116.
17. Risch C., Janowsky D.S., Gillin J.C., Rauch J.L., Loengger B.L., Huey L.Y. Muscarinic supersensitivity of anterior pituitary ACTH release in major depressive illness, adrenal cortical dissociation. Psychopharmacol. Bull. 19:1983;343-346.
18. Sastry B.V.R., Janson V.E., Jaiswal N., Tayeb O.S. Changes in enzymes of the cholinergic system and acetylcholine release in the cerebra of aging male Fischer rats. Pharmacology. 26:1983;61-72.
19. Sitaram N., Gillin J.C. Development and use of pharmacologic probes of the CNS in man. Evidence of cholinergic abnormalities in primary affective illness. Biol. Psychiatry. 18:1980;467-475.
20. Vogel G., Hartley P., Neil D., Hagler N., Kors D. Animal depression model by neonatal clomipramine: reduction of shock induced aggression. Pharmacol. Biochem. Behav. 31:1988;103-106.
21. Vogel G., Neil D., Hagler N., Kors D. A new animal model of endogenous depression: a summary of present findings. Neurosci. Biobehav. Rev. 14:1990;85-91.
22. Zakut H., Matzkel A., Schejter E., Avni A., Soreq H. Polymorphism of acetylcholinesterase in discrete regions of the developing human fetal brain. J. Neurochem. 45:1985;382-389.